Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor

Area of Science:

• Biochemistry
• Genetics
• Public Health

Background:

• X-linked adrenoleukodystrophy (ALD) is a severe metabolic disorder affecting males, leading to adrenal insufficiency or fatal cerebral lesions.
• Newborn screening for ALD in males allows for early intervention, preventing irreversible damage and saving lives.
• Current screening protocols face challenges with ethical considerations regarding gender-specific testing.

Purpose of the Study:

• To design and validate a boys-only screening algorithm for ALD, avoiding unsolicited findings.
• To integrate this algorithm into the existing Dutch newborn screening program seamlessly.
• To assess the practical and ethical implications of gender-specific ALD newborn screening and establish a supportive follow-up protocol.

Main Methods:

• Development of a novel screening algorithm centered around the "X-counter" to identify males with ALD.
• Integration of the X-counter as a second-tier test within a four-tier screening process.
• Establishment of a patient- and parent-friendly, multidisciplinary, centralized follow-up protocol.

Main Results:

• A validated boys-only ALD screening algorithm, the "X-counter," was successfully developed.
• The algorithm is designed for seamless integration into the Dutch newborn screening program without generating unsolicited findings.
• A comprehensive and supportive follow-up protocol was established for affected individuals and their families.

Conclusions:

• The developed boys-only ALD screening algorithm provides a viable solution for countries with ethical considerations regarding gender-specific newborn screening.
• This approach can facilitate wider adoption of ALD newborn screening globally.
• The SCAN study demonstrates a successful model for implementing targeted newborn screening for X-linked conditions.